Brivaracetam Tablet, Film Coated
Product Images NDC 73473-906

The text provides information on the proportion of patients in a study evaluating the reduction in seizure frequency for different doses of Brivaracetam and a placebo. The data includes the number of patients in each group, categorized by the reduction in seizure frequency from baseline in percentage. The doses of Brivaracetam mentioned are 50 mg/day, 100 mg/day, and 200 mg/day.*

This text provides important information about a medication called Brivaracetam, which comes in tablet form with each tablet containing 10 mg of the active ingredient. The usual dosage instructions can be found in the accompanying prescribing information. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The medication is distributed by Solaris Pharma Corporation in Somerset, NJ, USA, and manufactured by Sunshine Lake Pharma Co., Ltd. in Guangdong Province, China. The National Drug Code for the tablets is 73473-904-60. A pharmacist is advised to dispense the accompanying Medication Guide with the 60 tablets, which are prescription-only.*

This text provides important information about brivaracetam tablets, with each tablet containing 25 mg of the active ingredient. It includes details on the usual dosage, storage conditions (20°C to 25°C), distribution and manufacturing locations, as well as a National Drug Code (NDC) number. Additionally, the text advises pharmacists to dispense the accompanying Medication Guide to each patient and indicates that the product is prescription-only.*

This text provides information about brivaracetam tablets, with each tablet containing 50 mg of the active ingredient. The usual dosage instructions are not specified and should be referred to prescribing information. The storage conditions recommend keeping the tablets between 20°C to 25°C and allow excursions between 15°C to 30°C. The tablets are distributed by Solaris Pharma Corporation in the USA and manufactured by Sunshine Lake Pharma Co., Ltd. in Guangdong Province, China. The National Drug Code (NDC) for the tablets is 73473-906-60. The text also instructs pharmacists to dispense the accompanying Medication Guide to each patient.*

This text provides detailed information about brivaracetam tablets, with each tablet containing 75 mg of the active ingredient. The tablets should be stored between 20°C to 25°C, with fluctuations permitted between 15°C to 30°C. The product is distributed by Solaris Pharma Corporation in the USA and manufactured by Sunshine Lake Pharma Co., Ltd. in Guangdong Province, China. The National Drug Code (NDC) for this product is 73473-907-60. The accompanying prescribing information should be consulted for the usual dosage and the pharmacist is instructed to dispense the Medication Guide to each patient. This entry also includes the recommended dosage of 60 tablets and the revision date of September 2025.*

Each tablet of this medication contains 100 mg of brivaracetam. The usual dosage information can be found in the prescribing information included. It is recommended to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). The product is distributed by Solaris Pharma Corporation in Somerset, NJ, USA, and manufactured by Sunshine Lake Pharma Co., Ltd. in Guangdong Province, China. Pharmacists should dispense the accompanying Medication Guide to each patient. The packaging contains 60 tablets and it is only available by prescription.*